Clinical Trials Directory

Trials / Completed

CompletedNCT02985099

1.2% Rosuvastatin Subgingivally Delivered In Chronic Periodontitis With Type 2 Diabetes Mellitus

1.2% Rosuvastatin Subgingivally Delivered In Treatment Of Chronic Periodontitis With Type 2 Diabetes Mellitus: A Placebo Controlled Clinical Trial

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Government Dental College and Research Institute, Bangalore · Academic / Other
Sex
All
Age
30 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of the present study was to evaluate the effects of subgingival delivery of 1.2% Rosuvastatin (RSV) gel as an adjunct to scaling and root planing in chronic periodontitis (CP) with Type 2 diabetes mellitus patients.

Detailed description

Background: The purpose of this double-masked, randomized, controlled clinical trial was to evaluate the effects of subgingival delivery of 1.2% Rosuvastatin gel as an adjunct to scaling and root planing (SRP) on clinical and radiographic parameters and compare this method with SRP plus placebo gel alone in chronic periodontitis (CP) with type 2 DM patients. Methods: Eighty CP patients with type 2 DM are included in this study. They were divided into two groups: 1) SRP + 1.2% Rosuvastatin gel (RSV group); 2) SRP + Placebo gel (Placebo group). At baseline, 3, 6 and 9 months after treatment, clinical measurements, including plaque index (PI), modified sulcus bleeding index (mSBI), probing depth (PD), clinical attachment level (CAL) and radiographic parameters intrabony defect depth (IBD), percentage change in radiographic defect depth reduction (DDR%) were assessed.

Conditions

Interventions

TypeNameDescription
DRUGSRP plus Rosuvastatin gelSRP followed by 1.2% Rosuvastatin placement into intrabony defect
DRUGSRP plus placebo gelSRP followed by placebo gel placement into intrabony defect

Timeline

Start date
2015-11-01
Primary completion
2016-07-01
Completion
2016-07-01
First posted
2016-12-07
Last updated
2016-12-07

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT02985099. Inclusion in this directory is not an endorsement.